APA (7th ed.) Citation

Blasi, L., Sabbatini, D., Fortuna, A., Querin, G., Martinelli, I., Vianello, S., . . . Sorarù, G. (2023). The value of serum creatinine as biomarker of disease progression in spinal and bulbar muscular atrophy (SBMA). Scientific Reports, 13(1), 1. https://doi.org/10.1038/s41598-023-44419-6

Chicago Style (17th ed.) Citation

Blasi, Lorenzo, et al. "The Value of Serum Creatinine as Biomarker of Disease Progression in Spinal and Bulbar Muscular Atrophy (SBMA)." Scientific Reports 13, no. 1 (2023): 1. https://doi.org/10.1038/s41598-023-44419-6.

MLA (9th ed.) Citation

Blasi, Lorenzo, et al. "The Value of Serum Creatinine as Biomarker of Disease Progression in Spinal and Bulbar Muscular Atrophy (SBMA)." Scientific Reports, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1038/s41598-023-44419-6.